Terms: = Skin cancer AND GATA3, HDR, 2625, ENSG00000107485, MGC5445, MGC5199, MGC2346 AND Clinical Outcome
4 results:
1. Electronic brachytherapy for non-melanoma skin cancer in Asians: Experience from a Taiwan medical center.
Tang TY; Tang JY; Chu-Sung Hu S; Chiao-Li Ke K; Cheng ST
J Formos Med Assoc; 2022 Nov; 121(11):2317-2323. PubMed ID: 35570050
[TBL] [Abstract] [Full Text] [Related]
2. Complete response of endemic Kaposi sarcoma lesions with high-dose-rate brachytherapy: treatment method, results, and toxicity using skin surface applicators.
Kasper ME; Richter S; Warren N; Benda R; Shang C; Ouhib Z
Brachytherapy; 2013; 12(5):495-9. PubMed ID: 23466358
[TBL] [Abstract] [Full Text] [Related]
3. clinical outcome after treatment with a brachytherapy boost versus external beam boost for anal carcinoma.
Oehler-Jänne C; Seifert B; Lütolf UM; Studer G; Glanzmann C; Ciernik IF
Brachytherapy; 2007; 6(3):218-26. PubMed ID: 17681244
[TBL] [Abstract] [Full Text] [Related]
4. High-dose-rate (hdr) or pulsed-dose-rate (PDR) perioperative interstitial intensity-modulated brachytherapy (IMBT) for local recurrences of previously irradiated breast or thoracic wall following breast cancer.
Niehoff P; Dietrich J; Ostertag H; Schmid A; Kohr P; Kimmig B; Kovács G
Strahlenther Onkol; 2006 Feb; 182(2):102-7. PubMed ID: 16447017
[TBL] [Abstract] [Full Text] [Related]